title: Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
abstract: OBJECTIVE
  Endometrioid carcinoma of the ovary is the third most common type of epithelial ovarian cancer. Endometrioid tumors as well as endometriotic implants are characterized by the presence of epithelial cells, stromal cells, or a combination of booth, that resemble the endometrial cells, suggesting a possible endometrial origin of these tumors. Th1 cytokines including interleukin (IL)-1 have been reported to be involved in both endometriosis and ovarian carcinogenesis. We assessed the expression of receptors of IL-1 (IL-1RI and IL-1RII, the signal transducer and the specific inhibitor of IL-1, respectively) in cells of the most common subtypes of ovarian cancer compared to endometrial cells.
  
  
  METHODS
  IL1-Rs expression was analyzed at the levels of the protein and mRNA using immunofluorescent and real-time polymerase chain reaction methods, respectively.
  
  
  RESULTS
  We showed that endometrioid cells exhibit a specific decrease of IL-1RII expression, whereas IL-1RI was constantly expressed in all studied cell subtypes.
  
  
  CONCLUSIONS
  As already reported in endometriotic cells, endometrioid ovarian cancer cells exhibit the same alteration in the expression of IL-1RII, a key protector against tumorigenic effects of IL-1. Our findings highlight a common signature between endometrioid ovarian cancer and implants of endometriosis, which needs to be fully explored.
authors.affiliation: Department of Obstetrics and Gynecology, Sherbrooke University Hospital Centre, Sherbrooke, Quebec, Canada.
authors.forename: Mamadou
authors.initials: M
authors.lastname: Keita
authors.forename: Youssef
authors.initials: Y
authors.lastname: AinMelk
authors.forename: Manuella
authors.initials: M
authors.lastname: Pelmus
authors.forename: Paul
authors.initials: P
authors.lastname: Bessette
authors.forename: Aziz
authors.initials: A
authors.lastname: Aris
mesh_terms: D018269:Carcinoma, Endometrioid / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D004715:Endometriosis / Q000235:genetics / Q000378:metabolism*; D004717:Endometrium; D004847:Epithelial Cells; D005260:Female; D005455:Fluorescent Antibody Technique; D015870:Gene Expression; D006801:Humans; D019044:Image Cytometry; D010049:Ovarian Diseases / Q000235:genetics / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000235:genetics / Q000378:metabolism*; D053573:Receptors, Interleukin-1 Type I / Q000096:biosynthesis*; D053574:Receptors, Interleukin-1 Type II / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: C508592:IL1R2 protein, human; D053573:Receptors, Interleukin-1 Type I; D053574:Receptors, Interleukin-1 Type II